OpenPGx – Ask Claude about medications from your 23andMe/Genera raw file (MCP) (github.com)

OpenPGx has launched an innovative, AI-readable standard for pharmacogenomic data that enables users to inquire about medication compatibility based on their genetic profiles harnessing raw data from platforms like 23andMe and Genera. Using a privacy-first MCP Server, users can integrate OpenPGx with AI systems such as Claude and ask personalized questions about drug interactions and genetic disease risks, all while ensuring that their data remains on their computer with no cloud involvement. This standard provides structured JSON data that can be easily consumed by AI systems, marking a significant shift from traditional, unstructured formats. The significance of OpenPGx lies in its ability to democratize access to pharmacogenomic knowledge, enhancing personalized medicine by allowing users to understand how their genetic makeup affects their responses to various medications. Each gene-drug study within OpenPGx is rooted in reputable research, facilitating accurate interpretations that support informed healthcare decisions. With 67 studies covering 63 genes and 127 drugs, users can query their results in a user-friendly manner, receive risk assessments for 19 diseases, and even access trait analyses. This move not only improves patient care but also opens the door for further developments within the AI/ML community in healthcare analytics and genetic data interpretation.